Traduction de «some achievements and figures for the bum department » (Néerlandais → Français) :

SOME ACHIEVEMENTS AND FIGURES FOR THE BUM DEPARTMENT IN 2007
SOME ACHIEVEMENTS AND FIGURES FOR THE BUM DEPARTMENT IN 2007

SOME ACHIEVEMENTS AND FIGURES FOR THE R&D DEPARTMENT IN 2007
SOME ACHIEVEMENTS AND FIGURES FOR THE R&D DEPARTMENT IN 2007

Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.
Some achievements and figures for the Veterinary Medicines unit in 2007 KPIs and measurement results The most important KPI for this unit is the proportion of the number of finalised applications to the number of new, submitted applications, as a measure of the evolution of the unit’s backlog.

Some achievements and figures for Unit I in 2007 With the current team of inspectors, 733 routine inspections were performed at retail pharmacies and 89 at hospital pharmacies and of stocks of medicines in care institutions in 2007.
Some achievements and figures for Unit I in 2007 With the current team of inspectors, 733 routine inspections were performed at retail pharmacies and 89 at hospital pharmacies and of stocks of medicines in care institutions in 2007.

Some achievements and figures for Unit II in 2007 Rapid alerts relating to the quality of medicines The Rapid Alerts System or RAS network is an international network whose purpose is to circulate information as quickly as possible about batches of medicines that have been identified as nonconforming, which were produced in non-GMP conditions or which do not belong to the distribution circuit that complies with the GDP.
Some achievements and figures for Unit II in 2007 Rapid alerts relating to the quality of medicines The Rapid Alerts System or RAS network is an international network whose purpose is to circulate information as quickly as possible about batches of medicines that have been identified as nonconforming, which were produced in non-GMP conditions or which do not belong to the distribution circuit that complies with the GDP.